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Excess perinatal morbidity and mortality continue to be major problems in developed and
developing nations. Most perinatal deaths occur in infants born weighing <2500 g. Large ex-
penditures oftime, equipment, and personnel have led to striking reductions in neonatal mor-
tality. However, rates of prematurity have not declined. Exploration of proven causes of
prematurity and low birth weight suggests a role for infection that has hitherto not received
sufficient attention. Women with symptomatic pyelonephritis, even when treated promptly,
experience an excess of prematurity and perinatal death, and their children have lowered in-
telligence scores and neurologic scores. Women with asymptomatic bacteriuria experience
higher rates oflow birth weight and perinatal mortality, as well as symptomatic pyelonephritis,
and these are preventable by screening and treatment during pregnancy. Recent evidence also
suggests that genital mycoplasmas (Ureaplasma urealyticum and Mycoplasma hominis) are a
cause of prematurity and that treatment of women colonized with these organisms results in
significant reduction in prematurity rates.
INTRODUCTION
The unique role that Dorothy Horstmann has played in scientific progress has
come from her capacity to synthesize laboratory evidence with the most precise use
ofepidemiologic methods. This skill and her unusual interpersonal talents arethe in-
gredients of leadership, and it is this leadership, manifest in many contributions to
the health of the community, that is a source of honor beyond the mere words that
her devoted colleagues can muster. It is her devotion to the use of scientific method
for the improvement of health that exemplifies her career and forces each of us, as
we contemplate her achievements, to reexamine the many areas in which progress is
needed to achieve still better health.
Few areas of medicine have received as much adverse comment and yet as little
scientific attention as have perinatal morbidity and mortality in the United States.
We are continually reminded that the United States ranks between fifteenth and
twentieth in the world with respect to perinatal mortality and that this status has
changed little over the past several decades in relation to that ofother populations of
the developed world, despite remarkable advances in neonatology [1,2]. These sober-
ing figures require critical examination in order to determine 'where progress is
needed. As a corollary, it is reasonable to expect that the lessons learned from at-
tempts to reduce excess perinatal morbidity in the United States will be valuable to
developing countries.
An analysis of a subject as complex as is perinatal morbidity and mortality re-
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All rights of reproduction in any form reserved.quires an initial segregation of certain portions of the problem even at the risk of
oversimplification. Therefore, the following list comprises a series of general
statements that provide a basis for recent speculations about newly acquired data
and offer a possible rationale for preventive intervention.
1. The most important determinant of perinatal morbidity and mortality is the
social class of the mother. The major reason that the United States compares un-
favorably in international ranking is because of the high perinatal mortality rates in
the less privileged segments of the American population [1,2].
2. Although obstetric care is a factor in reducing perinatal morbidity and mortal-
ity, and although less-privileged populations tend to receive less obstetric care than
the more-privileged, critical analysis ofthe role of obstetric care suggests that only a
relative minority of all instances of perinatal morbidity and a minority of high-risk
pregnancies are recognizable during the course of pregnancy and, therefore, might
be amenable to preventive intervention. Although obstetric services should be ex-
tended to provide each pregnant woman with the advantages of contemporary
knowledge, it is unlikely that a major reduction of perinatal morbidity can be
achieved at present by such care unless more information about prevention becomes
available [1-4].
3. The most salient feature of the patterns of perinatal mortality is that the ma-
jority of infants that died in the neonatal and postnatal periods had birth weights of
less than 2500 grams. This excess mortality in the small infant is as true in more-
privileged as it is in underprivileged populations, and the adverse effect of being
born small extends throughout the first several months of life [5]. This effect often
goes unnoticed because mortality in postnatal data tends to be listed under cause-
specific titles, so that malaria, respiratory, and diarrheal diseases are listed as prin-
cipal causes of death. The uncommon susceptibility of small infants to these infec-
tions is widely recognized clinically but is rarely reflected in demographic statistics.
Conversely, although infants who are heavier at birth are probably exposed to the
same types of infectious agents, and, in underprivileged populations, undoubtedly
have high infectious morbidity, their capacity to survive is greater than that of in-
fants born small.
4. The mean weight at birth of infants in social class V (unskilled laborers) is ap-
proximately 80-100 grams less than the mean weight of infants born to mothers of
social class I (professionals). Therefore, remarkably small differences in the weight
of the newborn infants have profound effects on their capacity to survive in an en-
vironment that has substantial hazards. The small differences among birth weights
of infants in the various social classes and, therefore, the small increases in birth
weight that are the objective of preventive measures have generally not been ap-
preciated [3]. On the other hand, most of the weight of the developing infant is ac-
quired during the last weeks of pregnancy. Therefore, the factors interfering with
birth weight exert their greatest influence during the last weeks before delivery, and
these weeks are critical to development as well as to the degree of susceptibility to ex-
cess mortality and other morbidity.
5. Remarkable advances in neonatology have led to progressive declines in infant
mortality in institutions that have been able to take advantage of these advances.
The underlying fact, however, is that the number of babies born at low weights and
numbers of premature deliveries have changed little in recent years [6]. Those in-
fants that have been salvaged under high-risk conditions that might previously have
led to death have a risk of 8 percent-15 percent of having serious developmental dif-
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ficulties for their entire lives [7]. The cost of neonatal intensive care is high, averag-
ing at least $1000 a day in most institutions, and there is ample evidence that the
length of stay in a neonatal intensive care unit is inversely proportional to birth
weight of the infant. Despite the major advances of the past decades, repeated
analyses of the problem have suggested that prevention of low birth weight is the
most effective and economic intervention that can be contemplated. The
neonatologist is necessarily concerned with the survival of each infant and has
available an enormous range of technical facilities. Insufficient attention has been
given to the corresponding need to investigate more effective ways of preventing
these perinatal catastrophes.
PREVENTION OF PREMATURE DELIVERY
The problem of prevention of premature delivery is complicated by a number of
features:
First among these is the inadequacy ofpresent methods ofpredicting the high-risk
pregnancy. Customarily, clinicians use factors such as age, race, blood pressure,
past reproductive history, and presence or absence ofexcessive edema or proteinuria
as indicators of high-risk pregnancies. Such indicators, however, have not generally
been quantitatively analyzed, and it is well-known in obstetric clinics that they iden-
tify only a minority of the high-risk pregnancies that will actually occur.
We have attempted to quantitate the risk indicators using modern multiple regres-
sion methods. A list of thirty-five "predictors," collected at the twentieth week of
pregnancy, were analyzed; only a small number of these factors were significantly
predictive of low birth weight. These were put into a multiple regression format as
follows:
Birth wt. (oz) = 0.2026 x maternal weight + 7.73 (if white) - 6.29 (if smoker)
- 0.2217 x lowest recorded systolic blood pressure + 0.0517 x plasma
volume - 4592 x age + 3.42 x no. live-born children - 2.35 x no. live-
born pregnancies + 97.99.
The multiple R for these predictors was approximately 0.4. Thus, only 16 percent
of the variability in birth weight was explained through these measurements. Ob-
viously many predictors remain to be identified.
Complicating the problem still further has been the complex problem of
categorizing low-birth-weight infants. Although a large amount of epidemiologic
data has been accumulated showing that low birth weight is still the best predictor of
perinatal mortality, there are understandable attempts to define the categories of
low birth weight more precisely. A variety of developmental scores and chemical
analyses continue to be developed. None is as yet completely satisfactory.
Often overlooked is the interrelation between gestational age (although it is a poor
measurement based upon memory or on measurements whose validity is still uncer-
tain) and birth weight; the close relation between these two variables has been de-
fined mathematically. Using the formulas of Goldstein et al. [7], it is possible to
predict the extent of perinatal mortality and the subdivisions of prematurity in any
large cohort of pregnant women simply because, in any group of low-birth-weight
deliveries, a certain number will be small for gestational age, another group will be
premature by gestational age, and so on, and yet the relative distribution within
these subdivisions will occur with fairly regular frequency within any large cohort of
pregnant women.
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Similarly, low birth weight and perinatal mortality, as indicated above, tend to
have a fairly fixed relationship. Thus, a sensitive indicator of the efficacy of in-
tervention would be an effect on birth weight. After such an effect had been
demonstrated, it would become economical and feasible to explore in larger popula-
tions the effects ofintervention on both the various subdivisions oflow birth weight
and on perinatal mortality. The relation between perinatal mortality and low birth
weight is such that it requires a study approximately eight to ten times larger to find
significant effects on mortality than to find significant effects on birth weight. A
strategy that seeks first to identify preventive approaches that alter birth weight
would be an efficient first step, but would be useful only if it were followed by a
larger study that securely established effects on immaturity, prematurity, and mor-
tality. On the other hand, to design studies that would use these latter factors as end
points, without earlier having established an effect on birth weight alone, would ap-
pear to be inefficient and expensive.
ROLE OF INFECTION ON OUTCOME OF PREGNANCY
Since antiquity it has been known that a febrile disease has a high likelihood ofex-
erting an adverse effect on the course of a pregnancy. This observation has been
confirmed in so many ways in the preantibiotic years that it no longer needs further
documentation. With the advent of specific antimicrobial therapy, it was im-
mediately apparent that the adverse effects of infections on the outcome of preg-
nancy could be greatly ameliorated. It was widely assumed, therefore, that the
adverse effect of infections on pregnancy was completely overcome. However, the
possibility that antimicrobial treatment brought about a reduction in risk, rather
than an elimination of excess risk, was not explored systematically until relatively
recently.
BACTERIURIA AND PREGNANCY
The studies on the effect of bacteriuria on the outcome of pregnancy demon-
strated that when bacteriuric women developed symptomatic pyelonephritis
of pregnancy and were treated promptly, they still had a high risk of low-birth-
weight deliveries and of perinatal mortality [8]. These demonstrations have received
critical confirmation in the recent observations by Sever et al. [9] who analyzed the
outcome of pregnancies having febrile complications among the 56,000 pregnant
women who were participants in the National Maternal and Infant Health Study
conducted in 17 obstetric centers throughout the United States. It was found that
pyelonephritis of pregnancy contributed approximately five times as many febrile
episodes during pregnancy as did other viral infections. Women diagnosed as having
pyelonephritis of pregnancy were, ofcourse, treated promptly by the obstetric staff.
Nevertheless, these pyelonephritic pregnancies were associated with a striking
number of low-birth-weight babies, increased perinatal mortality, and a variety of
other perinatal morbid events such as anemia, toxemia, elevated blood pressure, and
premature rupture of the membranes [9]. In addition, children born of mothers who
had developed pyelonephritis during pregnancy and been treated had lower in-
telligence quotient scores at seven years of age than did the children of non-
pyelonephritic mothers, despite correction for a variety ofpossible confounding fac-
tors such as age, race, social class, parity, and so on. Furthermore, children born of
pyelonephritic mothers had lower motor function scores than did the others.
It is not clear whether detection of asymptomatic bacteriuria earlier in pregnancy,
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thereby eliminating the risk of pyelonephritis, would have prevented these excess
risks. All that is established at present is that the early detection of bacteriuria dur-
ing pregnancy and its elimination virtually eliminate the risk of symptomatic
pyelonephritis and that bacteriuric pregnancies are accompanied by an excessive risk
of low birth weight and perinatal mortality, including stillbirth. Intervention to
eliminate bacteriuria might have a beneficial effect on the other morbidities that ac-
company symptomatic pyelonephritis ofpregnancy, but it would take a major study
to establish the point. Such a study would be manifestly cost-efficient when the
nature of the morbidity that is encountered in pyelonephritic pregnancies is con-
sidered. Whether such a study can be funded at present is uncertain, to say the least.
The awareness that subclinical as well as clinically apparent infections may alter
the course of pregnancy has led to the search for other examples of this
phenomenon. A chance observation made in our laboratory many years ago sug-
gested that pregnant women who received tetracycline during pregnancy had
substantially fewer low-birth-weight deliveries than did women who received a
placebo [10]. (These studies were conducted before the effect of tetracycline on
tooth staining was recognized and therefore were discontinued when the tetracycline
effect became known.) A search for a possible explanation for the phenomenon led
to an examination of the possible role of genital mycoplasmas on the outcome of
pregnancy. A number of observations have been made in our laboratory and by
other research groups suggesting a pattern that requires much more detailed study.
GENITAL MYCOPLASMAS AND LOW BIRTH WEIGHT
Initially it was demonstrated that approximately 80 percent of the pregnant
women in the low-income population at a major municipal hospital were colonized
with the two major genital mycoplasmas, Ureaplasma urealyticum and Mycoplasma
hominis, together or separately [11]. Women colonized with these mycoplasmas
delivered significantly smaller infants than women who were not colonized. Infants
in a consecutive series studied by Klein et al. [12] were found to be colonized with
genital mycoplasmas in inverse relation to birth weight; small infants were almost in-
variably colonized, and the large infants were much less frequently colonized. In-
fants born by cesarian section were not colonized. This observation suggested ac-
quisition of colonization during passage through the birth canal and indicated an
association between high levels of colonization, or of increased susceptibility to col-
onization, and low birth weight. A study of chorioamnionitis and vascular inflam-
mation in placentas and umbilical cords indicated a significant association between
such inflammatory changes in the membranes and vessels and the likelihood of col-
onization, particularly with Ureaplasma [13]. Kundsin et al. [14] demonstrated that
when the chorion was cultured after delivery there was a substantially higher
likelihood of isolating genital mycoplasmas from those pregnancies in which the in-
fant received intensive care or those accompanied by perinatal mortality compared
with full-term normal deliveries.
Most recently, by use of a newly developed mycoplasmacidal test, it has been
found that rises in titers of antibodies to either or both of the genital mycoplasmas
delineates a group of pregnancies with two- to threefold higher risk of low-birth-
weight delivery than in pregnancies where such antibody rises are absent [15]. It ap-
pears from preliminary information that the excess risk oflow-birth-weight delivery
is found largely in women who have experienced rises in antibody titers to both
genital mycoplasmas in the same pregnancy.
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Concurrently, McCormack et al. have demonstrated in a double-blind study that
those women receiving 1 g of erythromycin daily for six weeks during the third
trimester of pregnancy have a striking reduction in the rate of low-birth-weight
delivery, whereas women receiving the treatment during the second trimester have
no significant reduction [15] over rates in women given a placebo. Presumably, the
latter group became reinfected after treatment had stopped. At present, however,
there is no proof that the effect of erythromycin is mediated exclusively, or at all,
through an effect on genital mycoplasmas. This question is one for future research
to address.
The conclusion that seems warranted is that genital mycoplasmas play a role in the
outcome of pregnancy, particularly in low-income women, and that antimicrobial
drugs alter favorably the outcome of pregnancy in low-income women. A few
studies in private practice patients indicate that the rate of colonization with genital
mycoplasmas is 50 percent, as opposed to 80 percent in low-income women. It is not
yet known whether colonization with genital mycoplasmas in women with higher in-
comes has an effect on birth weight, or whether antibiotics have any effect on
pregnancy.
Calculations of the effect of mycoplasmas on the outcome of pregnancy in the
low-income population indicate that as much as half of the excess of low birth
weight in this population (compared with the higher-income population), can be
related to the rises in titers of antibody to genital mycoplasmas occurring during
pregnancy.
OTHER PATHOGENS THAT MAY AFFECT PREGNANCY
Several other microorganisms ofthe genital tract have recently received attention.
These include group B streptococci [16], Chlamydia, various anaerobes, and many
other genital microorganisms. Space does not permit a review of the present status
of these latter organisms in affecting the outcome of pregnancy.
The case for large-scale, carefully controlled observations that integrate the ef-
fects of these various organisms, determine whether they act separately or together,
and explore the most effective preventive measures seems to be strong.
The circle becomes complete when we contemplate the role of Dorothy
Horstmann in demonstrating how clinical trials should be conducted in large
populations, for critically examining the implications of the data, and for providing
to the medical world an appreciation of the significance of the results thereby ob-
tained. Would that her expertise were available for the solution of the problems of
the role of infection in the pathogenesis of perinatal morbidity and mortality!
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